Concurrent image-guided intensity modulated radiotherapy and chemotherapy following neoadjuvant chemotherapy for locally advanced nasopharyngeal carcinoma

Radiation Oncology

Volumn 6, Issue 1, 2011, Pages

  Shueng, Pei Wei ^a,b   Shen, Bing Jie ^a   Wu, Le Jung ^a   Liao, Li Jen ^a   Hsiao, Chi Huang ^a   Lin, Yu Chin ^a   Cheng, Po Wen ^a   Lo, Wu Chia ^a   Jen, Yee Min ^b   Hsieh, Chen Hsi ^a,c  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Concurrent chemoradiation; Helical tomotherapy; Intensity modulated radiotherapy; Nasopharyngeal carcinoma

Indexed keywords

CISPLATIN; EPIRUBICIN; FLUOROURACIL; FOLINIC ACID;

ADULT; ADVANCED CANCER; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RELAPSE; CANCER STAGING; CLINICAL ARTICLE; DERMATITIS; DISTANT METASTASIS; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LEUKOPENIA; LYMPH NODE METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE FRACTIONATION; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT RESPONSE; XEROSTOMIA; ADJUVANT THERAPY; CARCINOMA; DISEASE FREE SURVIVAL; IMAGE GUIDED RADIOTHERAPY; METHODOLOGY; MIDDLE AGED; NASOPHARYNX TUMOR; RADIOMETRY; RECURRENT DISEASE; REGRESSION ANALYSIS; TREATMENT OUTCOME;

ADULT; CARCINOMA; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOADJUVANT THERAPY; RADIOMETRY; RADIOTHERAPY, IMAGE-GUIDED; RADIOTHERAPY, INTENSITY-MODULATED; RECURRENCE; REGRESSION ANALYSIS; TREATMENT OUTCOME;

EID: 80051593789     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-6-95     Document Type: Article

References (25)

1. Baujat B, Audry H, Bourhis J, Chan AT, Onat H, Chua DT, Kwong DL, Al-Sarraf M, Chi KH, Hareyama M, Leung SF, Thephamongkhol K, Pignon JP. Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys 2006, 64:47-56. 10.1016/j.ijrobp.2005.06.037, 16377415.
2. Langendijk JA, Leemans CR, Buter J, Berkhof J, Slotman BJ. The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature. J Clin Oncol 2004, 22:4604-12. 10.1200/JCO.2004.10.074, 15542811.
3. Huncharek M, Kupelnick B. Combined chemoradiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma: results of a meta-analysis of 1,528 patients from six randomized trials. Am J Clin Oncol 2002, 25:219-23. 10.1097/00000421-200206000-00002, 12040275.
4. Lee NY, Le QT. New developments in radiation therapy for head and neck cancer: intensity-modulated radiation therapy and hypoxia targeting. Semin Oncol 2008, 35:236-50. 10.1053/j.seminoncol.2008.03.003, 2494523, 18544439.
5. Mavroidis P, Shi C, Plataniotis GA, Delichas MG, Costa Ferreira B, Rodriguez S, Lind BK, Papanikolaou. Comparison of the helical tomotherapy against the multileaf collimator-based intensity-modulated radiotherapy and 3D-conformal radiation modalities in lung cancer radiotherapy. Br J Radiol
6. Hsieh CH, Kuo YS, Liao LJ, Hu KY, Lin SC, Wu LJ, Lin YC, Chen YJ, Wang LY, Hsieh YP, Lin SL, Chen CY, Chen CA, Shueng PW. Image-guided intensity modulated radiotherapy with helical tomotherapy for postoperative treatment of high-risk oral cavity cancer. BMC Cancer 2011, 11:37. 10.1186/1471-2407-11-37, 3037924, 21269518.
7. Hsieh CH, Liu CY, Shueng PW, Chong NS, Chen CJ, Chen MJ, Lin CC, Wang TE, Lin SC, Tai HC, Tien HJ, Chen KH, Wang LY, Hsieh YP, Huang DY, Chen YJ. Comparison of coplanar and noncoplanar intensity-modulated radiation therapy and helical tomotherapy for hepatocellular carcinoma. Radiat Oncol 5:40.
8. Wu WC, Mui WL, Fung WK. Helical tomotherapy of nasopharyngeal carcinoma-any advantages over conventional intensity-modulated radiotherapy?. Med Dosim 35:122-7.
9. Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, Langer C, Murphy B, Cumberlin R, Coleman CN, Rubin P. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003, 13:176-81. 10.1016/S1053-4296(03)00031-6, 12903007.
10. Dinse GE, Lagakos SW. Nonparametric estimation of lifetime and disease onset distributions from incomplete observations. Biometrics 1982, 38:921-32. 10.2307/2529872, 7168795.
11. Hasbini A, Mahjoubi R, Fandi A, Chouaki N, Taamma A, Lianes P, Cortes-Funes H, Alonso S, Armand JP, Cvitkovic E, Raymond E. Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal type. Ann Oncol 1999, 10:421-5. 10.1023/A:1008342828496, 10370784.
12. Lee N, Xia P, Quivey JM, Sultanem K, Poon I, Akazawa C, Akazawa P, Weinberg V, Fu KK. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 2002, 53:12-22. 10.1016/S0360-3016(02)02724-4, 12007936.
13. Kwong DL, Pow EH, Sham JS, McMillan AS, Leung LH, Leung WK, Chua DT, Cheng AC, Wu PM, Au GK. Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function. Cancer 2004, 101:1584-93. 10.1002/cncr.20552, 15378492.
14. Kam MK, Teo PM, Chau RM, Cheung KY, Choi PH, Kwan WH, Leung SF, Zee B, Chan AT. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys 2004, 60:1440-50. 10.1016/j.ijrobp.2004.05.022, 15590175.
15. Wolden SL, Chen WC, Pfister DG, Kraus DH, Berry SL, Zelefsky MJ. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys 2006, 64:57-62. 10.1016/j.ijrobp.2005.03.057, 15936155.
16. Lin JC, Jan JS, Hsu CY, Liang WM, Jiang RS, Wang WY. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol 2003, 21:631-7. 10.1200/JCO.2003.06.158, 12586799.
17. Lee N, Harris J, Garden AS, Straube W, Glisson B, Xia P, Bosch W, Morrison WH, Quivey J, Thorstad W, Jones C, Ang KK. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol 2009, 27:3684-90. 10.1200/JCO.2008.19.9109, 2720082, 19564532.
18. Kim K, Wu HG, Kim HJ, Sung MW, Kim KH, Lee SH, Heo DS, Park CI. Intensity-modulated radiation therapy with simultaneous integrated boost technique following neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma. Head Neck 2009, 31:1121-8. 10.1002/hed.21076, 19340863.
19. Wong FC, Ng AW, Lee VH, Lui CM, Yuen KK, Sze WK, Leung TW, Tung SY. Whole-field simultaneous integrated-boost intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 76:138-45.
20. Kodaira T, Tomita N, Tachibana H, Nakamura T, Nakahara R, Inokuchi H, Fuwa N. Aichi cancer center initial experience of intensity modulated radiation therapy for nasopharyngeal cancer using helical tomotherapy. Int J Radiat Oncol Biol Phys 2009, 73:1129-34. 10.1016/j.ijrobp.2008.06.1936, 18922651.
21. Ma J, Mai HQ, Hong MH, Min HQ, Mao ZD, Cui NJ, Lu TX, Mo HY. Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. J Clin Oncol 2001, 19:1350-7.
22. Al-Amro A, Al-Rajhi N, Khafaga Y, Memon M, Al-Hebshi A, El-Enbabi A, El-Husseiny G, Radawi A, Belal A, Allam A, El-Sebaie M. Neoadjuvant chemotherapy followed by concurrent chemo-radiation therapy in locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2005, 62:508-13. 10.1016/j.ijrobp.2004.09.050, 15890594.
23. Miah AB, Bhide SA, Guerrero-Urbano MT, Clark C, Bidmead AM, St Rose S, Barbachano Y, A'Hern R, Tanay M, Hickey J, Nicol R, Newbold KL, Harrington KJ, Nutting CM. Dose-Escalated Intensity-Modulated Radiotherapy Is Feasible and May Improve Locoregional Control and Laryngeal Preservation in Laryngo-hypopharyngeal Cancers. Int J Radiat Oncol Biol Phys
24. Mohan R, Wu Q, Manning M, Schmidt-Ullrich R. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys 2000, 46:619-30. 10.1016/S0360-3016(99)00438-1, 10701741.
25. Bonneterre J, Roche H, Kerbrat P, Fumoleau P, Goudier MJ, Fargeot P, Montcuquet P, Clavere P, Barats JC, Monnier A, Veyret C, Datchary J, Van Praagh I, Chapelle-Marcillac I. Long-term cardiac follow-up in relapse-free patients after six courses of fluorouracil, epirubicin, and cyclophosphamide, with either 50 or 100 mg of epirubicin, as adjuvant therapy for node-positive breast cancer: French adjuvant study group. J Clin Oncol 2004, 22:3070-9. 10.1200/JCO.2004.03.098, 15284257.